Sanara MedTech (SMTI) Invested Capital (2010 - 2026)

Sanara MedTech has reported Invested Capital for 16 years, with the latest figure at $7.0 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 80.83% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (down 80.83% YoY), and the FY2025 full-year result was $5.9 million, down 84.76% from the prior year.
• Invested Capital for Q1 2026 stood at $7.0 million, up from $5.9 million in the prior quarter.
• The five-year high for Invested Capital was $54.3 million in Q4 2023, with the low at $5.9 million in Q4 2025.
• Historically, Invested Capital has averaged $35.4 million across 5 years, with a median of $39.5 million in 2022.
• Annual changes were most pronounced in 2023 — Invested Capital surged 45.46% — and 2025, when it tumbled 84.76%.
• Sanara MedTech's Invested Capital stood at $41.7 million in 2022, then jumped by 30.24% to $54.3 million in 2023, then fell by 28.39% to $38.9 million in 2024, then plunged by 84.76% to $5.9 million in 2025, then increased by 18.53% to $7.0 million in 2026.
• The last three Invested Capital figures came in at $7.0 million (Q1 2026), $5.9 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.